Selectins (L-, E-and P-selectin) are calcium-dependent transmembrane glycoproteins that are expressed on the surface of circulating leukocytes, activated platelets, and inflamed endothelial cells. Selectins bind predominantly to sialofucosylated glycoproteins and glycolipids (E-selectin only) present on the surface of apposing cells, and mediate transient adhesive interactions pertinent to inflammation and cancer metastasis. The rapid turnover of selectin-ligand bonds, due to their fast on-and off-rates along with their remarkably high tensile strengths, enables them to mediate cell tethering and rolling in shear flow. This paper presents the current body of knowledge regarding the role of selectins in inflammation and cancer metastasis, and discusses experimental methodologies and mathematical models used to resolve the biophysics of selectin-mediated cell adhesion. Understanding the biochemistry and biomechanics of selectin-ligand interactions pertinent to inflammatory disorders and cancer metastasis may provide insights for developing promising therapies and/or diagnostic tools to combat these disorders.
Introduction
Cell adhesion in shear flow is instrumental in diverse biological processes including inflammation and cancer metastasis. Leukocyte recruitment to sites of inflammation or infection is mediated by highly specific receptor-ligand interactions that allow leukocytes to first tether and roll on activated endothelium under hydrodynamic shear and then firmly adhere prior to their extravasation into the tissue space. During the metastatic process, tumor cells invade the surrounding tissues to reach and penetrate the vascular endothelium. Once they enter the circulatory system, these rogue cancerous cells, referred to as circulating tumor cells (CTCs), are subjected to shear forces and immunological stresses, which may affect their ability to metastasize. Only tumor cells uniquely fit to overcome or even exploit the effects of hemodynamic 4 Both authors contributed equally to this work. 5 Author to whom any correspondence should be addressed.
forces and immunosurveillance will adhere to the vascular endothelium of distant organs, extravasate and successfully colonize these sites. Thus, only a tiny fraction of CTCs is capable of establishing secondary colonies (Fidler et al 2002) ; most CTCs die or remain dormant. Understanding the molecular and biophysical underpinnings of CTC adhesion to host cells in shear flow may provide guidelines for developing promising anti-metastatic therapies when initiated early in the course of disease progression.
Accumulating evidence suggests that the adhesive interactions of CTCs with host cells, such as platelets, leukocytes and endothelial cells, modulate their extravasation from the vasculature, and thus the development of secondary metastatic foci. For instance, CTCs may escape immune surveillance and promote their extravasation from the circulatory system by co-opting platelets. Direct evidence for the involvement of platelets in the facilitation of hematogenous dissemination of tumor cells stems from studies showing inhibition of metastasis by either pharmacological (Gasic et al 1968 , Karpatkin et al 1988 or genetic depletion (Camerer et al 2004) of platelets, and the restoration of metastatic potential by platelet infusion in a mouse model (Karpatkin et al 1988) . It is believed among others that platelets, by forming heterotypic adhesive clusters with CTCs (Borsig et al 2001 (Borsig et al , 2002 , mask and protect CTCs from immune-mediated mechanisms of clearance (Nieswandt et al 1999 , Palumbo et al 2005 . Alternatively, platelets may potentiate tumor cell adhesion to the vessel wall via a platelet bridging mechanism, in which platelets adherent to an endothelial-bound tumor cell capture free-flowing CTCs that subsequently attach to the vessel wall downstream or next to the already adherent cell (Burdick and Konstantopoulos 2004) . Platelets may also secrete an array of bioactive compounds, such as vascular endothelial growth factor (VEGF) at points of attachment to endothelium, thereby promoting vascular hyperpermeability and extravasation (Nash et al 2002) . Once tumor cells have exited the circulation, factors released from activated platelets are capable of inducing angiogenesis and stimulating growth at the metastatic site (Pinedo et al 1998) . CTCs can also hijack polymorphonuclear leukocytes (PMNs) for arrest in the endothelium of distant organs. PMN-facilitated CTC arrest under hydrodynamic shear involves initial PMN tethering on the endothelium and subsequent capture of freeflowing tumor cells by tethered PMNs. CTCs may also masquerade as immune cells and directly bind to vascular endothelium in a manner analogous to leukocyte recruitment, which involves tethering, rolling and firm adhesion (Burdick et al 2003, Burdick and Konstantopoulos 2004) . Selectins mediate the initial tethering and rolling events during leukocyte accumulation to sites of inflammation. Similarly, selectins facilitate cancer metastasis (Borsig et al 2001 , Mannori et al 1997 and tumor cell arrest in the microvasculature by mediating the specific interactions between selectinexpressing host cells and ligands on tumor cells (Burdick and Konstantopoulos 2004 , Burdick et al 2003 , Jadhav et al 2001 , McCarty et al 2000 . Indeed, a variety of tumor cells, such as colon and pancreatic carcinoma cells, express sialofucosylated molecules that are recognized by selectins (Mannori et al 1995 , Park et al 2003 , Satomura et al 1991 .
The adhesion of leukocytes and CTCs to endothelial cells involves highly regulated molecular events such as selectin-ligand interactions that rely on the local circulatory hemodynamics and the micromechanical and kinetic properties of participating adhesive molecular constituents. Fluid shear generated by blood flow, on one hand, induces collisions among free-flowing cells as well as between freeflowing cells and the vessel wall, thereby increasing the encounter rate between membrane-bound receptors and their cognate ligands. On the other hand, fluid shear reduces the cell-cell contact duration, and exerts tensile forces tending to disrupt the receptor-ligand bonds that are responsible for cell adhesion. Particle size and compliance also modulate the extent of cell adhesion in shear flow (Jadhav et al 2005 , Pawar et al 2008 . The ability to predict cell-cell binding will be vital to the optimization of design parameters, such as site density, affinity and tensile strength of targeted receptorligand interactions, for developing effective targeted drug delivery strategies to combat inflammatory disorders and cancer metastasis.
In this paper we discuss the critical roles of selectins and newly discovered functional selectin ligands in cancer metastasis. We proceed with a description of experimental techniques and mathematical models used to resolve the biophysics of selectin-mediated cell adhesion pertinent to inflammation. These biophysical/mathematical approaches can be readily applied to resolve the selectin-ligand binding interactions in the area of cancer metastasis. Understanding the biochemical and biophysical underpinnings of selectinligand interactions pertinent to inflammation and cancer metastasis may provide insights for combating these disorders.
Selectins and selectin ligands on host cells and tumor cells
Selectins are calcium-dependent transmembrane glycoproteins that recognize specific glycoconjugates on apposing cell surfaces (Kansas 1996 , Varki 1997 , and play pivotal roles in the cell-cell interactions pertinent to inflammation and cancer metastasis. All three known members of the selectin family (L-, E-, and P-selectin) share a similar cassette structure: an N-terminal, calcium-dependent lectin domain, an epidermalgrowth-factor (EGF)-like domain, a variable number of consensus repeat units (2, 6, and 9 for L-, E-, and P-selectin, respectively), a transmembrane domain (TM) and an intracellular cytoplasmic tail (cyto). Though they share common elements, their tissue distribution and binding kinetics are quite different, reflecting their divergent roles in various pathophysiological processes.
L-selectin (CD62L) is constitutively expressed on the surface of almost all types of leukocytes but gets rapidly shed upon cell activation with cytokines, chemokines, or formyl peptides. Expression of P-selectin (CD62P) on endothelium and platelet surfaces is inducible. E-selectin (CD62E) expression is induced on vascular endothelial cells and requires de novo mRNA and protein synthesis. Maximal level of E-selectin expression typically occurs 4-6 h after activation with inflammatory stimuli, such as interleukin-1, tumor necrosis factor-alpha or endotoxin in vitro. P-selectin is stored preformed in the Weibel-Palade bodies of endothelial cells and alpha-granules of platelets, and is rapidly mobilized to the plasma membrane upon activation with agonists like histamine or thrombin. However, P-selectin expression on vascular endothelium may also be regulated at the transcriptional level after stimulation with cytokines such as interleukin-4 or oncostatin M (Yao et al 1996) .
Selectins, like all C-type lectins, bind to carbohydrate ligands in a calcium-dependent manner. Detailed studies involving site-directed mutagenesis, domain swapping, and antibody inhibition have revealed that carbohydrate ligands bind to the lectin domain on a shallow region that overlaps a single calcium coordination site opposite where the EGF domain is located (Kansas 1996 , Varki 1997 . Evidence also suggests that the EGF domain and the short consensus repeat domains not only contribute to ligand specificity but also confer unique kinetic and mechanical properties on Figure 1 . Schematic diagram of selectin-ligand interactions between tumor cells and host vascular cells. CD44 on free-flowing tumor cells binds to P-selectin on activated endothelial cells or platelets, whereas CD44, CEA, and PCLP mediate E-selectin-dependent tumor cell adhesion to endothelial cells. CD44, CEA, and PCLP also bind to L-selectin expressed by leukocytes. Adopted from Konstantopoulos and Thomas (2009). each selectin when binding to its ligand (Patel et al 1995b (Kansas 1996 , Varki 1997 . sLe x is a terminal component of glycans attached to glycoproteins and glycolipids on most circulating leukocytes and some endothelial cells. In contrast, sLe a is expressed on some tumor cells but not on normal leukocytes. The affinity of selectins for isolated monovalent sLe x and sLe a oligosaccharides is very low (Nicholson et al 1998 , Poppe et al 1997 . Thus, neither expression of the sLe x nor the sLe a groups correlate with the properties of endogenous selectin ligands on cellular targets per se. Instead, sLe x or related structures are part of more extensive binding determinants. Selectins can also recognize other classes of molecules, namely nonsialylated or non-fucosylated molecules such as heparan sulfate glycosaminoglycans, sulfated glycolipids such as sulfatides, and sulfoglucuronosyl glycosphingolipids (Varki 1997) .
High affinity ligands for P-and L-selectin have been identified (figure 1). P-selectin binds to the amino terminus of P-selectin glycoprotein ligand-1 (PSGL-1; CD162), which is expressed on nearly all blood leukocytes, human hematopoietic progenitor cells (McEver and Cummings 1997a) , and to a much lesser extent on blood platelets (Frenette et al 2000) . The extracellular domain of PSGL-1 (∼60 nm long) has the hallmarks of a mucin, since it is rich in serines, threonines and prolines, and includes 16 decameric repeats (McEver and Cummings 1997b) . High affinity binding of PSGL-1 to P-and L-selectin requires three clustered tyrosine sulfate residues, adjacent peptide components, and fucose and sialic acid residues on an optimally positioned short core-2 O-glycan within the anionic amino-terminal region of PSGL-1 (Leppanen et al 2000) . Crystallographic studies reveal a patch of positive electrostatic potential on P-selectin designed to engage the tyrosine sulfate residues and increase the binding affinity (Somers et al 2000) . Although PSGL-1 is recognized by all three selectins (Hanley et al 2004 , Patel et al 1995a , it serves as functional ligand only for P-and L-selectin, since selective removal or blockade of PSGL-1 on intact human leukocytes nearly abrogates their binding to P-and L-selectin (Patel et al 1995b , Walcheck et al 1996 . In contrast, PSGL-1 appears dispensable for E-selectin-dependent binding of human PMNs (Nimrichter et al 2008) .
L-selectin also binds to a series of mucin-type glycoproteins such as CD34, podocalyxin-like protein (PCLP) and MadCAM-1 that contain O-linked glycans in which the sLe x determinant is present and further substituted with a sulfate ester on the 6-hydroxyl group of the GlcNAc (NeuAc a2,3 Gal ß1,4 [Fuc a1,3] SO36-GlcNAc; 6-sulfo-sLe x ) and/or Gal (NeuAc a2,3 SO36-Gal ß1,4 [Fuc a1,3] GlcNAc; 6 -sulfosLe x ) residues (Rosen 2004) . The sulfate residue on GlcNAc is required for high-affinity L-selectin-dependent binding, while the contribution of Gal-6-sulfation is controversial (Rosen 2004) .
Although E-selectin binds to PSGL-1 (Hanley et al 2004) , accumulating evidence supports the concept that sialylated fucosylated glycolipids on human PMNs represent the physiologically relevant E-selectin ligands (Alon et al 1995a , Burdick et al 2001 , Nimrichter et al 2008 . Also, L-selectin itself has been reported as a high-affinity ligand for E-selectin. Direct evidence for this interaction was provided in affinity isolation experiments with E-selectin-Ig, which also documented that the binding was dependent on sialic acid on L-selectin (Zollner et al 1997) . Although the inhibitory effects of anti-L-selectin mAbs on PMN binding to E-selectin-coated surfaces were initially ascribed to the blockade of the so-called secondary tethering mediated by L-selectin on free-flowing cell and L-selectin ligands on already adherent leukocytes (Alon et al 1996) , it has been reported that antibody blockade interferes with primary interactions between L-and E-selectin (Zollner et al 1997) .
A variety of tumor cells, including colon and pancreatic carcinoma cells, express sialofucosylated molecules (Mannori et al 1995 , Park et al 2003 , Satomura et al 1991 , Kannagi 1997 ) that are recognized by selectins. However, the characterization of selectin ligands on tumor cells beyond general classifications (i.e. sialofucosylated mucinlike glycoproteins) has recently begun to emerge.
As described by Varki (1997) , distinctions must be drawn between molecules that can bind to selectins under static conditions in vitro and those (i.e. the functional ligands) that actually interact with selectins in vivo. To this end, a functional selectin ligand should fulfill certain criteria: it should be expressed in the right place and at the right time, the ligand should bind with some selectivity and relatively high affinity, and selective removal or absence of the ligand should prevent cell adhesive interactions. CD44 variant isoforms, CD44v, have been identified as P-selectin ligands that fit the aforementioned criteria (Napier et al 2007) (figure 1). CD44 proteins are type I transmembrane molecules encoded by a single gene that comprises at least 20 exons. Exons 1-5, 16-18 and 20 are spliced together to form the smallest CD44 transcript, known as standard isoform (CD44s). However, CD44s displays a rather low affinity for P-selectin (Hanley et al 2006) . It is believed that the structural biology of CD44 is such that splicing of variant exons into CD44 by metastatic tumor cells extends its molecular length and inserts additional sites for glycosylation, thereby transforming CD44v into a mucin-like sialofucosylated glycoprotein capable of functioning as an efficient P-selectin ligand. CD44v also serves as an ancillary L-selectin ligand by stabilizing L-selectin-dependent tumor cell rolling (Napier et al 2007) . In contrast, CD44 appears dispensable for E-selectin-dependent binding (Napier et al 2007) . Of note, CD44v overexpressing in certain types of cancer confers resistance to apoptosis, metastatic potential in vivo and leads to prognosis (Harada et al 2001 , Wielenga et al 1993 .
Carcinoembryonic antigen (CEA) was recently shown to possess L-and E-, but not P-, selectin ligand activity on colon carcinoma cells (Thomas et al 2008a) (figure 1). Most importantly, CEA and CD44v cooperate to mediate colon carcinoma cell adhesion to L-and E-selectin in shear flow (Thomas et al 2008a) . Interestingly, CEA is expressed in a number of tumors of epithelial origin including colorectal carcinoma, lung adenocarcinoma and mucinous ovarian carcinoma, and has been reported to promote the metastatic potential of colon carcinoma cells (Hashino et al 1994 , Minami et al 2001 . PCLP was also found to support Land E-, but not P-selectin-dependent tethering and rolling of metastatic colon carcinoma cells in shear flow (Thomas et al 2009a) (figure 1). The selectin-binding determinants on PCLP expressed by tumor cells are non-sulfated (MECA-79-negative) sialofucosylated structures displayed on O-linked glycans (Thomas et al 2009a (Thomas et al , 2009b , distinct from the MECA-79-reactive O-glycans expressed by high endothelial venules, which possess L-selectin ligand activity. Of note, PCLP is expressed by a number of metastatic tumor cells such as colon and breast carcinoma (Somasiri et al 2004 , Thomas et al 2009a . PCLP overexpression has been reported as an independent predictor of breast cancer progression (Somasiri et al 2004) .
The role of selectins in cancer metastasis
Mounting evidence suggests that selectins facilitate the hematogenous dissemination of tumor cells and their arrest in the microvasculature by mediating specific interactions between selectin-expressing host cells and ligands on tumor cells. The most direct evidence for the involvement of Pselectin in the metastatic process is the marked inhibition of metastasis in P-selectin-deficient mice compared to wild-type (wt) controls in a colon carcinoma cell model (Borsig et al 2001 , Kim et al 1998 . Microscopic observations of tumor cells arrested in the lungs of wt mice reveal the presence of a dense coat of platelets surrounding the colon carcinoma cells that is diminished in P-selectin-deficient mice (Borsig et al 2001) . Moreover, the initial seeding and subsequent lodging of metastatic cells in target organs was mitigated in P-selectin-knockout mice compared to wt controls (Borsig et al 2001 , Kim et al 1998 . Although these observations suggest that platelet P-selectin plays a critical role not only in colon carcinoma-platelet adhesion but also in the facilitation of metastasis, they cannot rule out an additional role for endothelial P-selectin that could potentially tether tumor cells and mediate their extravasation from the vasculature. In vivo studies also disclose the role of L-selectin in cancer metastasis (Borsig et al 2002) . It is believed that tumor cells can form multicellular complexes with platelets and leukocytes (via an L-selectin-dependent mechanism) (Jadhav et al 2001, Jadhav and , which can then arrest in the microvasculature of distant organs, and eventually extravasate and establish metastatic colonies. Selectins can thus act synergistically to facilitate tumor cell-host cell interactions and cancer metastasis. To date, the cooperative effects of Pand L-selectin on cancer metastasis have been demonstrated in vivo (Borsig et al 2002) . Interestingly, leukocyte L-selectin can also enhance metastasis by interacting with endothelial Lselectin ligands induced adjacent to established intravascular colon carcinoma cell emboli (Laubli et al 2006) . Endothelial E-selectin has been shown to support metastatic spread in vivo (Mannori et al 1997) . Since selectins recognize sLe xand/or sLe a -decorated glycoproteins such as CD44v, CEA and PCLP, and over-expression of these moieties on tumor cells correlates with poor prognosis and tumor progression (Kannagi 1997 , Konstantopoulos and Thomas 2009 , Thomas et al 2009b , it appears that selectin-mediated adhesion to these sialofucosylated target molecules on tumor cells is an important determinant for metastatic spread.
The ability of selectin-ligand bonds to initiate tethering and rolling in shear flow is dictated by their micromechanical and kinetic properties, and their responses to external force. Below, we review quantitative models used to resolve the biophysics of receptor-ligand interactions.
Mathematical models of two-dimensional (2D) receptor-ligand binding affinity
Several techniques, such as surface plasmon resonance and radio-immunoassays, that have been developed to study receptor-ligand binding kinetics require at least one molecule present in solution, which limits their application to the measurement of three-dimensional (3D) binding constants. Yet, cell adhesive interactions are mediated by the binding of receptors to ligands, which are anchored on apposing cell membrane surfaces. Consequently, the motion of both molecules is restricted to 2D (Piper et al 1998) . Not only the binding mechanism is different but also their respective onrates have different units (M −1 s −1 in 3D and μm 2 s −1 in 2D). Even though 3D kinetic rates have been extensively reported in the literature, they are inadequate to describe the 2D kinetics of cell-cell adhesive interactions.
Sophisticated biophysical assays have been developed to quantify the 2D receptor-ligand binding kinetics. In the widely used micropipette aspiration assay (Evans et al 1991), a red blood cell, serving as a picoforce transducer, coated with a low density of the adhesion receptor of interest is held at a fixed position by a micropipette. Also held by a second micropipette, a cell (PMN) or a ligand-bearing bead is translated to contact the RBC by precision-piezo displacements for prescribed durations of time, and then retracted from the contact position at defined pulling velocities. The deformation of the RBC induced by the receptor-ligand bond is recorded using a video-enhanced microscope. The bond rupture force is readily calculated by multiplying the total extension of RBC with the stiffness of membrane transducer at the moment of bond failure (Evans et al 1991 (Evans et al , 1995 . In addition to measuring force-dependent 2D off-rates, the micropipette aspiration assay can also be used to quantify the 2D affinity constant, A c K a 0 , of receptor-ligand bonds (Huang et al 2010 , Chesla et al 1998 , as described below.
In this assay, the small contact zone between the target cell (or ligand-bearing bead) and the receptor-coated RBC along with the low site density of adhesion molecules dictate that receptor-ligand binding occurs as a random event, even though all experimental conditions can be kept identical including contact area (A c ), contact duration (t), surface density of receptors (m r ) and ligands (m l ). Hence, the probabilistic model, rather than the deterministic model, is more suitable for this scenario (Chesla et al 1998 , McQuarrie et al 1964 .
For a 1-step reversible kinetic system involving v r receptors (R) binding to v l ligands (L) to produce v b bonds (B), its reaction equation is given by
where k 0 f and k 0 r represent the unstressed on-and offrates, respectively. The rates of change of the probability components (dp n /dt) are defined as (Chesla et al 1998) dp n dt = (n + 1)
where the first term on the right-hand side of equation (2a) represents the probability of (n + 1) bonds losing one bond during time t; the second and third terms represent the probability of n bonds adding one or losing one during time t, respectively; and the last term represents the probability of (n − 1) adding one bond during time t.
Assuming that the formation of a small number of receptor-ligand bonds will have no appreciable effect on the availability of unbound receptors and ligands inside the contact area, equation (2a) can be simplified by neglecting the n and
The solution of equation (2b) 
where n is the average number of bonds at time t given by
Equations (3) and (4) a is estimated from the steady-state value of the adhesion probability (P a,ss ) using equation (6). The unstressed dissociation rate k 0 r is determined from the half-time (t 50 ) using equation (7).
the Poisson distribution given by equation (3) is in excellent agreement with the exact solution if the ratio A c m min / n is >10.
In most chemical reactions, the concentration of the product is proportional to the reaction time until the system reaches equilibrium. Similar reaction characteristics have been observed for receptor-ligand-mediated cell adhesion to a surface (Chesla et al 1998) . An example plot showing the dependence of adhesion probability (P a ) on the contact duration (t) for different site densities of membrane-bound receptors and immobilized ligands is presented in figure 2 . Taking into consideration that the adhesion event is defined as having n 1 bonds, the dependence of receptor-ligand binding probability on the contact duration time is given by
The 2D binding affinity k 0 a and the unstressed off-rate k 0 r can be obtained by a simple graphic representation method, as shown in figure 2. By setting t → ∞ in equation (5), the steadystate solution P a,ss , which represents the maximum adhesion probability for a given set of conditions, is given by
The 2D affinity constant A c K 0 a can be estimated directly from the experiment data for a given set of receptor and ligand site densities. The unstressed off-rate k 0 r can be expressed by (Chesla et al 1998)
where t 50 represents the duration time for P a (t) to achieve 50% of steady-state value P a,ss as shown in the figure 2. Although we cannot directly estimate k 
Effects of molecular length and orientation on 2D binding kinetics
Cell adhesion is regulated not only by the intrinsic kinetic and mechanical properties of receptor-ligand pairs but also other geometric factors such as the length and orientation of adhesion molecules. The critical role of the molecular length in receptor-ligand binding kinetics was first demonstrated by rolling PSGL-1-expressing PMNs on different P-selectin constructs whose lengths were engineered by controlling the number of CR domains (Patel et al 1995b) . P-selectin constructs containing only two or three CR domains failed to support PMN binding in shear flow even though they exhibited a similar binding efficiency as that of native P-selectin under static conditions (Patel et al 1995b) . The impact of the molecular length on the 2D selectin-ligand binding kinetics was also investigated by the micropipette aspiration assay using two types of soluble P-selectin: P-selectin consisting of Lec-EGF domains plus 9 CR but no transmembrane and cytoplasmic domains, and P-selectin consisting of only the Lec-EGF domains with an added C-terminal epitope. The 2D affinity A c K 0 a of the long P-selectin molecule is ∼twofold larger than that of the short molecule; however, the molecular length did not have an appreciable effect on the unstressed off-rates k 0 r (Huang et al 2004) . Cumulatively, these findings suggest that the absence of PMN binding to immobilized Pselectin constructs bearing two or three CR domains (Patel et al 1995b) can be attributed to the poor accessibility of the short molecule to the ligand-coated surface. Once P-selectin-ligand bonds form, their dissociation is not altered by the length of the molecules.
The effect of molecular orientation on the 2D binding kinetics was also investigated using the micropipette aspiration assay. Soluble P-or E-selectin was either adsorbed randomly or uniformly coupled to non-blocking anti-P-or E-selectin antibodies, respectively, on the RBC surface. The 2D binding affinity of uniformly oriented selectins is markedly higher than that of randomly absorbed selectins, whereas no difference was noted in their respective unstressed off-rates (Huang et al 2004) . Taken together, the molecular length and orientation of selectins modulate the 2D selectin-ligand binding affinity without altering the unstressed off-rate.
Receptor-ligand dissociation: slip bond dissociation kinetics
The kinetic and micromechanical properties of receptorligand bond dissociation have been studied by the use of single-molecule force spectroscopy. There are two types of ultrasensitive probes: the biomembrane force probe (BFP) where force is sensed by the displacement of a glass microsphere attached to a pressurized membrane capsule (i.e. RBC) (Evans et al 2001 (Evans et al , 2004 , and the molecular force probe (MFP) where force is sensed by the deflection of a thin cantilever (Evans 2001 , Hanley et al 2003 , Marshall et al 2003 . Both techniques can quantify the tensile strength of receptor-ligand pairs at the single molecule level, and allow detection of a wide force spectrum ranging from 5 pN to >1 nN, which covers the typical biological forces from the molecular to the cellular level (Dobrowsky et al 2008 , Evans et al 2001 , Evans and Calderwood 2007 , Hanley et al 2003 , Marshall et al 2003 , Sarangapani et al 2004 , Helenius et al 2008 , Muller et al 2009 . In this section, we review the kinetic models of slip bond dissociation used to extract the biophysical properties of receptor-ligand pairs from BFP and MFP experiments. Slip bonds are defined as those whose bond lifetimes decrease with the application of an external force, because force reduces the energy barrier between bound and free states. Of note, all receptor-ligand pairs exhibit the slip bond dissociation kinetics in the high force regime.
When a receptor is in close proximity with a ligand, the bond formation can be described by a reversible bimolecular reaction with two discrete steps: receptor-ligand encounter and reaction. This conceptual design (Bell 1978 ) is expressed by where R is a free receptor molecule, L is a free ligand molecule, d + and d − are the rates of formation and dissociation of the encounter complex RL, r + and r − are the forward and reverse rates for the bond formation. In most cases, the concentration of RL complex is significantly lower than that of free receptor R and free ligand L. Consequently, equation (8) can be simplified by assuming each bond is formed directly from the pair of free molecules (Bell 1978) . The overall binding process is thus represented by
where k f and k r are the on-and off-rates of the bond resulting from a free receptor and a free ligand pair. In 1978, Bell proposed the force dependence of receptor-ligand bond dissociation, which is given by
where k 0 r is the unstressed off-rate, x β is the reactive compliance, f is the rupture force acting on the bond, k B T is the Boltzmann constant multiplied by the temperature (or thermal energy). The off-rate, k r , which is related to bond lifetime t b by t b = 1/k r , exponentially increases with the applied force. In the literature, k r is also given in the following form (Merkel et al 1999, Evans and Calderwood 2007) :
The new parameter f β = k B T/x β has units of force, and can be considered as the characteristic force scale at which the dissociation rate changes 2.7-fold. Equations (10) and (11) are commonly used to model slip bond dissociation under force. In practice, it is essentially impossible to apply a force instantaneously. Therefore, there is always a finite loading rate r f . Evans and colleagues (Evans and Ritchie 1997) proposed a model to estimate the dissociation parameters when a bond is ruptured by a finite loading rate. The probability of a single bond rupture in the time interval (t, t + dt) as a function of force is given by (Evans and Ritchie 1997)
where the exponential term represents the probability of bond survival up to time t, whereas the k r (f ) term represents the probability of bond rupture in the next short time interval dt. The peak value of this probability distribution can be obtained by taking the derivative of equation (12) with respect to f . By setting ϑp/ϑf = 0 and using the linear ramp of force, f (t) = r f ·t, the off-rate at the critical rupture force f b is given by
This equation suggests that the bond off-rate increases with the loading rate r f . Substituting the Bell model equation into equation (13) results in equation (14):
By plotting the rupture force f b against the logarithm of loading rate ln(r f ), the Bell model parameters, k 0 r and x β , can be estimated from the slope and intercept of experimental data in the linear region by using the following equations (Merkel et al 1999 , Tees et al 2001 , Hanley et al 2004 :
Alternatively, k 0 r and x β can also be estimated by a nonlinear least-squares fit of equation (16) 
The accuracy of the Bell model parameters can be validated by Monte Carlo simulations of receptor-ligand bond rupture under constant loading rates (Hanley et al 2003 (Hanley et al , 2004 . In brief, given values for k 0 r and x β in each simulation, the rupture force (F rup = r f ×n t) at a prescribed loading rate can be calculated for which the probability of bond rupture, P rup , is greater than P ran , a random number between 0 and 1:
where n = 1, 2, 3, . . . , t is the interval and n t is the time step.
Receptor-ligand dissociation: catch bond dissociation kinetics
The Bell model was proposed to describe the dissociation kinetics of the so-called slip bonds (Bell 1978) . Ten years later, Dembo proposed an alternative model, in which the off-rate increases exponentially with the square of applied force (Dembo et al 1988) . As a theoretical possibility, Dembo suggested that the bond lifetime may also increase with the applied force or remain unchanged; these bonds were classified as catch and ideal bonds, respectively. Catch binding is an intriguing and counter-intuitive phenomenon in which receptor-ligand bonds resist breakage and become stronger under the influence of a low externally applied force. Application of higher forces is expected to reduce the energy barrier between the bound and free states, and as such receptorligand bonds follow the slip dissociation kinetics. To date, at least four distinct receptor-ligand pairs show evidence of catch bond behavior in the low force regime and transition to slip bond dissociation at higher forces: selectin-ligand (Marshall et al 2003 , Sarangapani et al 2004 , glycoprotein Ib-von Willebrand factor , the bacterial adhesion protein FimH-mannose (Thomas et al 2002) , and integrin-ligand bonds (Kong et al 2009) . This seemingly paradoxical phenomenon at the nanoscale level translates into complex behavior witnessed at the cellular level, such as shear-threshold phenomenon in which the extent of cell binding to selectins, for instance, first increases and then decreases while monotonically increasing the wall shear stress (Finger et al 1996 , Lawrence et al 1997 .
The energy landscape that describes the dissociation of a slip bond has a bound state, which is separated from the free state by a potential energy barrier corresponding to the transition state. According to the Dembo model, the bound state and the transition state of a receptor-ligand bond are Hookean springs with specific elastic constants (k) and resting lengths (λ). If the elastic constant is the same for both springs but the difference between the resting lengths of the transition state and bound state springs, δλ, is positive, the off-rate of the receptor-ligand pair can be expressed as an exponential function of the applied force f (Dembo et al 1988) , as shown in equation (18). If the resting lengths are the same for both springs but the difference between the elastic constants of the transition state and bound state springs, δκ, is negative, the offrate increases exponentially as the square of the force (Dembo et al 1988) :
where k r is the off-rate in the presence of an applied force f , k 0 r is the unstressed off-rate and k is the elastic constant of the bound state. To account for the distinctions between slip and catch bonds, the possibilities of δλ < 0 and δκ > 0 were considered. In the latter scenarios, the off-rate decreases exponentially with the applied force or the square of force. It was thought that the application of external force on the catch bond decreases its failure rate in the low force regime, but this scenario switches to the traditional slip binding at higher forces where the applied force increases the failure rate.
Various physical and mathematical models have been proposed to describe the experimentally observed catch and slip bond behavior exhibited by selectin-ligand bonds. Conceptually, the receptor-ligand bond can be thought to be shaped like a harpoon or a hook. This configuration can lock 'tightly' when pulled apart by the two ends. Initially the unbinding time (or bond lifetime) increases with the applied force, indicative of catch bond behavior. Progressively increasing forces are capable of bending the elastic hook, thereby promoting dissociation via the slip pathway (Thomas et al 2008b) . Alternatively, the receptor can undergo a ligand-induced switch to an active conformation (Thomas et al 2008b) . The transition state in the catch pathway would reflect reversion to the inactive conformation followed by immediate receptor-ligand unbinding. The slip pathway would involve unbinding through the active conformation, similar to the forceful bending of the elastic hook.
A simple four-parameter model (Pereverzev et al 2005) was proposed to describe the unbinding of the selectin-ligand complex from a single bound state either along the catch bond pathway over a low-energy barrier or the slip bond pathway over a high-energy barrier. In the absence of an external force, the transition of the receptor-ligand complex from the bound to the free state is related to the thermal probability of reaching the top of the barrier. However, in the presence of an applied force, f , the height of the energy barrier E changes depending on the distance between the bound state 1 and the transition state 2 projected on to the direction of the externally applied force. When the applied tensile force pulls the bond from the bound state to the transition state by performing positive work on the ligand, the energy barrier is lowered ( figure 3) . The bond breakage in this case is through a single pathway where the projected distance is positive (x 12 > 0) and the receptor-ligand complex forms a slip bond. But force can also pull the ligand away from the transition state in such a way that the projected distance becomes negative (x 12 < 0). Under this circumstance, the force performs negative work on the ligand, thereby increasing the depth of the energy barrier E and decreasing the off-rate (figure 3). In other words, the applied tensile force increases the lifetime of the receptor-ligand bound complex thereby making it a catch bond (Dembo et al 1988 , Pereverzev et al 2005 .
The bound complex can dissociate from the bound state via two alternative paths that can be represented as two finite energy barriers on either side, for a catch-slip transition to occur. The probability that a ligand is still bound to its receptor at a later time t > 0, P(t), decreases with time according to equation (19) (Pereverzev et al 2005) :
where k 1c and k 1s are the dissociation rate constants for unbinding through the catch and slip pathways with the coordinates x c and x s , respectively. Along the two pathways, the exponential dependence of the dissociation rates on the applied force is given by the following relations:
where k 0 1c and k 0 1s are the unstressed dissociation rates along the catch and slip pathways, respectively. x 1c and x 1s are given Potential energy landscape for a one state two-pathway dissociation model for catch and slip bonds indicating that the energy barrier along the catch pathway has to be lower than the slip barrier for an efficient catch-slip transition to occur (blue line). The effect of force is depicted by the red line. Modified from Thomas et al (2008b) .
by x 1c = − − → x c − − → x 1 cos θ < 0; x 1s = − → x s − − → x 1 cos θ > 0 respectively. The solution to the equation for the survival probability is P(t) = exp[−(k 1c + k 1s )t], which implies that the two-pathway model arising from a single bound state displays a single exponential decay. The inverse mean lifetime of the bound state is given by
When the applied external force increases from zero, the bond lifetime increases, reaching a maximum value at critical force. Within this force regime, the receptor-ligand bonds exhibit longer lifetimes under force, which is indicative of catch bond behavior. This can be accomplished if k 1c decreases more rapidly than k 1s increases in the low force regime. However, above the critical force, the slip pathway dominates. A progressive increase in the applied force would accelerate dissociation along the slip pathway by suppressing the energy barrier. Using this model, the four parameters, namely, k
1s , x 1c and x 1s , were estimated for previously published experimental P-selectin-PSGL-1 data to be: (Pereverzev et al 2005) , and found to be in good agreement with MFP data (Hanley et al 2004) .
Evans and colleagues (Evans et al 2004) proposed another two-pathway model, in which the receptor-ligand bond can dissociate along two force-dependent pathways from two bound states that are in thermal equilibrium with each other. A rapid inner conversion between the two states was assumed, which reduced the model parameters from nine to five. The switch from the low impedance pathway (which has a fast dissociation rate) to the high impedance pathway (which has a slow dissociation rate) by the application of an external force is governed by the change in the occupancies of the two bound states, and this determines the transition from catch to slip bond behavior (Evans et al 2004) . P-selectin-PSGL-1 was found to act as a mechanochemical switch where the force history ascertains the pathway along which the receptor-ligand complex dissociates (Evans et al 2004) . This hypothesis was tested using a novel jump/ramp mode of force spectroscopy (Evans et al 2004) .
Experimental demonstration of selectin-ligand catch-to-slip bond transition
The first experimental observation of catch bonds was provided by Zhu and colleagues using force spectroscopy and flowbased adhesion assays (Marshall et al 2003) . In force spectroscopy experiments, the dimeric form of PSGL-1 or the monomeric recombinant soluble PSGL-1 (sPSGL-1) immobilized on the cantilever was brought repeatedly in contact with P-selectin incorporated into polymer supported lipid bilayers. After applying a constant force to the bond, its lifetime was recorded and plotted as a function of the force producing a characteristic biphasic pattern. In the low force regime, the bond lifetime increased with increasing the force, indicative of the catch bond behavior. Above a critical force level, the bond lifetime decreased with the force, reflective of traditional slip bond behavior. Interestingly, the bond lifetimes and critical force for P-selectin-dimeric PSGL-1 binding were double relative to those for P-selectin-sPSGL-1 binding suggesting that sPSGL-1 forms monomeric bonds with P-selectin, whereas the native form of PSGL-1 forms dimeric bonds with P-selectin (Marshall et al 2003) . These force spectroscopy observations were validated by the use of flow-based assays. Independent experiments performed by Evans and colleagues (Evans et al 2004) using a BFP with a combination of the 'steady ramp' and 'jump/ramp' modes of force spectroscopy also confirmed that P-selectin-PSGL-1 bonds display the catch-to-slip bond transition.
L-selectin binding to its ligands, PSGL-1 and endoglycan, was also found to exhibit catch bond behavior at low forces and transition to slip bond at higher forces (Sarangapani et al 2004) . In contrast to P-selectin, L-selectin is only capable of making monomeric bonds with PSGL-1 (Sarangapani et al 2004) .
Both L-selectin and PSGL-1 are expressed on the surface of circulating leukocytes and play a key role in homotypic leukocyte adhesive interactions in shear flow Konstantopoulos 2002, Taylor et al 1996) . Without the catch bonds to shorten bond lifetimes in the low shear regime, spontaneous homotypic aggregation of free-flowing leukocytes via an L-selectin-PSGL-1-dependent mechanism would be induced with undesirable clinical manifestations. Catch bonds thus function to prevent leukocyte aggregation when it is not needed (Zhu et al 2005) .
Estimation of bond dissociation rates from cell rolling assays
In flow-based adhesion assays, the translational velocity at any given instant describes different types of cell motion (Hammer Specifically, a cell is in free motion when its translational velocity is close to the prevailing hydrodynamic velocity. When the cell mean velocity is significantly slower than the hydrodynamic velocity due to the formation/dissociation of receptor-ligand bonds, the cell is classified as in rolling motion. If a cell is stationary for at least several seconds, it is considered as firmly adherent. Although cell rolling is a complex process controlled by many different physical and chemical parameters, such as cell deformation, microvillus extension, receptor and ligand site densities, and receptorligand bond formation and dissociation, several simplifications can still possibly be made. In the low shear regime, the cell deformation can be neglected such that the cell can be modeled as a hard sphere in a Couette flow. The hydrodynamic force and torque exerted on the cell can be determined by F x = 1.7 × (6πμR 2 S) and T y = 0.944×(4πμR 3 S), respectively (Goldman et al 1967) , where μ is the viscosity of the suspended buffer, R is the radius of cell and S is the shear rate. If ligands are immobilized on the substrate at very low site densities, the binding interaction can be assumed to involve a single receptor-ligand bond complex. Thus, the bond lifetime can be obtained by simply recording the cell tethering time.
The bond rupture force F b can be estimated by balancing forces and torques on the cell at static equilibrium, as shown in figure 4 . The sum of forces in x-or z-directions must equal zero:
where F o is the contact force between cell and flow chamber in the y-direction. The balance of torque in the y-direction about the contact point of F o is given by
The length of the lever arm is equal to the distance between the binding point and the contact point of F o (figure 4) which can be measured by the distance that bound cells move during flow reversal assays (Chen et al 1997 , Alon et al 1997 . The tether length d (figure 4) is the total length of an extended microvillus and the receptor-ligand complex (Alon et al 1997 , Chen et al 1997 , Shao et al 1998 . The oriented angle θ of the tether is expressed by (Shao et al 1998) 
To ensure that cell tethering is mediated by a single receptorligand pair, flow-based adhesion assays must be performed using a substrate (i.e. chamber wall) coated with very low selectin site densities, typically, lower than those supporting stable cell rolling. The cell tethering time, t b , represents the bond lifetime. Under a constant force, the dissociation of tethered cells follows the first order kinetics (Alon et al 1995b) . By plotting the natural logarithm of the number of cells that remained tethered as a function of lifetime, the dissociation rate k r can be extracted by the negative slope of the fitting curve as shown in figure 5(a) (Alon et al 1995b , Alon et al 1997 . By performing the flow chamber assays under different wall shear stresses, the off-rate k r can be obtained as a function of applied force, which is calculated from equations (23)- (26). The independence of off-rate on the selectin site density on the substrate is indicative of a quantum unit mediating selectin-dependent cell tethering (Alon et al 1995b) . The kinetic parameters of selectin-ligand bond dissociation can be obtained by fitting the appropriate kinetic model (e.g. twopathway model (Evans et al 2004) ) to the off-rate data as a function of force ( figure 5(b) ).
Effects of fluid shear on cell rolling
In the absence of viscous fluid moving around a cell, its translational velocity U cell would be synchronized with the angular velocity when the modeled cell is in the limit of touching the surface. Hence, R /U cell would be equal to unity. However, the numerical solutions of R /U cell obtained by Goldman et al (1967) showed that the value of R /U cell approaches a finite limit of ∼0.5676 when z → R (e.g. the modeled cell 'touches' the surface) ( figure 4) . Consequently, the cell translational velocity U cell is always larger than the surface tangential velocity R , leading to a cell slipping motion relative to the chamber wall. This slipping velocity has been shown to enhance the receptorligand encounter rate (Chang and Hammer 1999) . In the absence of a slipping motion between the cell surface and the chamber wall, each cell receptor could only interact with a limited number of immobilized counter-receptors located within its reactive zone. In contrast, when a cell surface moves with a finite slipping velocity, each cell receptor can potentially react with any counter-receptor passing its reactive zone. Although fluid shear exerts forces tending to disrupt the receptor-ligand bonds responsible for cell tethering/adhesion, it also induces collisions between free-flowing cells and the vessel wall, thereby increasing the encounter rate between membrane-bound receptors and their ligands (Caputo et al 2007, Chang and Hammer 1999 leukocyte attachment to inflamed endothelial cells during the inflammatory response, but can also enhance tumor cell adhesion to vascular endothelium, thereby increasing the risk of tumor cell extravasation to secondary tissues. Selectin-PSGL-1-dependent interactions require a shear threshold to mediate optimal leukocyte tethering and rolling (Lawrence et al 1997 . In other words, leukocyte tethering rate first increases and then decreases while monotonically increasing wall shear stress. This so-called shear threshold phenomenon seems counter-intuitive because increasing levels of shear stress increase the dissociation force on the bonds, thereby increasing the probability of the cell to detach from the substrate. Both in vitro and in vivo assays reveal that this phenomenon may be characteristic of all three selectins binding to their respective glycoprotein ligands (Finger et al 1996 , Lawrence et al 1997 . Shearinduced cell deformation was initially proposed to explain this phenomenon by increasing the contact area between the cell and the substrate; as such, the probability of bond formation is increased (Lawrence et al 1997) . However, numerical studies show that cell deformation plays a modest role in the shear threshold phenomenon (Pawar et al 2008) . In light of observations showing that cell-free flow assays using purified selectins and their respective ligands successfully recapitulate the shear threshold phenomenon (Marshall et al 2003 , it is now accepted that the origin of this phenomenon is primarily molecular, intimately linked with the kinetic and micromechanical properties of receptorligand bonds.
Based on the analysis of various biophysical parameters that control selectin-mediated adhesion under flow, Zhu and colleagues identified two major mechanisms that contribute to the shear threshold phenomenon (Zhu et al 2008) : transportdependent acceleration of bond formation and force-dependent deceleration of bond dissociation. The first mechanism encompasses three distinct modes of transport (Zhu et al 2008) : (i) the relative sliding between the cell and the surface; (ii) the Brownian motion, which alters the gap distance between the cell and the surface and increases their collisions; and (iii) the molecular diffusivity of the receptors and ligands, which orients their binding sites for molecular docking. The second mechanism refers to the catch bond kinetics in which the bond lifetime is prolonged by the tether force. Interestingly, simulation studies using the adhesive dynamics model for cell rolling reveal that the shear-threshold phenomenon observed in L-selectin-dependent cell rolling is predominantly attributed to the catch-slip bond kinetics and to a lesser extent to the shear-controlled on rate (Caputo et al 2007) . Dimensional analysis studies also disclose that the tether force, but not the wall shear rate or wall shear stress, is the critical parameter controlling flow-enhanced cell rolling (Zhu et al 2008) .
Concluding remarks
The mechanisms used for trafficking of leukocytes may be appropriated for the dissemination of metastatic tumor cells via the bloodstream and lymphatics. In particular, the paradigm of the coordinated action of a 'rapid' selectin-dependent binding followed by a 'slow' integrin-mediated adhesion has been extended to account for maximal binding of tumor cells to activated endothelium (Burdick and Konstantopoulos 2004, Burdick et al 2003) , platelets (McCarty et al 2000 (McCarty et al , 2002 , and PMNs (Jadhav et al 2001 , Jadhav et al 2007 under physiological shear conditions. Significant advances have recently been made in the identification and characterization of functional selectin ligands expressed by metastatic tumor cells (Napier et al 2007 , Thomas et al 2008a , which appear to be distinct from the selectin ligands found on the leukocyte surface. Although the biophysics of selectin-mediated leukocyte binding has been extensively studied, little is known about the biomechanics of selectin-ligand interactions in the context of cancer metastasis (Hanley et al 2003) . Since these interactions precede and are thus necessary for tumor cell extravasation, and facilitate CTC survival and metastatic outgrowth, a quantitative analysis of selectin-ligand binding will further our understanding of the metastatic process and aid the development of new screening methods and therapeutic strategies that exploit these binding interactions. Elucidating the molecular nature of tumor cell adhesion in the dynamic setting of the vasculature requires a multidisciplinary approach that integrates fundamentals of hydrodynamics, modeling of receptor-ligand binding kinetics and cell mechanics, with concepts and techniques from biochemistry and molecular and cell biology.
